Inhibikase Therapeutics Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Inhibikase Therapeutics stock have an average target of 5.50, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 191.01% from the current stock price of 1.89.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$4.00	$5.50	$6.00	$8.00
Change	+111.64%	+191.01%	+217.46%	+323.28%

Analyst Ratings

The average analyst rating for Inhibikase Therapeutics stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	1	1	1	2	2	3
Buy	0	0	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	3	4	4	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Aydin Huseynov Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Initiates $4	Strong Buy	Initiates	$4	+111.64%	Mar 4, 2026
Jason Zemansky B of A Securities	B of A Securities	Strong Buy Initiates $6	Strong Buy	Initiates	$6	+217.46%	Jan 21, 2026
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $8	Strong Buy	Initiates	$8	+323.28%	Dec 26, 2025
Olivia Brayer Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates $4	Buy	Initiates	$4	+111.64%	Dec 11, 2025
Edward White HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 28, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

288.57K

EPS This Year

-0.51

from -0.31

EPS Next Year

-0.54

from -0.51

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	698.47K	3.10M	123.44K	260.50K	-	-	288.57K
Revenue Growth	-37.79%	343.92%	-96.02%	111.04%	-	-	-
EPS	-2.08	-4.87	-4.28	-3.16	-0.31	-0.51	-0.54
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	n/a	2.1M
Avg	n/a	288,567
Low	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

EPS Forecast

EPS	2025	2026
High	-0.46	-0.39
Avg	-0.51	-0.54
Low	-0.56	-0.98

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.